[
フレーム]
Please make JavaScript on and see this site.
Back
-
Regulations & Services of PMDA
Information about Approved Products in Japan
-
Information for approved products in Japan
-
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnostics
Information for approved products in Japan
-
Regulations and services of PMDA
Information for approved products in Japan
Back
-
Regulations and Services of PMDA
Information for apporoved products in Japan
-
Regulations and Services of PMDA
Information for apporoved products in Japan
-
Reviews and Related Services
Post-marketing Safety Measures
-
Reviews and Related Services
Post-marketing Safety Measures
Regulatory Science/The Science Board/Standard Development
The 4th Subcommittee on Rare Cancers
Press Release
Date and Time:April 28, 2017 from 4pm to 6pm
Agenda / List of Handouts
Agenda
- Clinical Trials of Rare Cancers Area (Dr. Taro Shibata, a Member of the Subcommittee)
- Clinical Sarcoma Research, Rare Cancers Research and Development (Dr. Seiichi Matsumoto, a Member of the Subcommittee)
- Experience in Childhood Cancers Research Group, Rare Cancers Research and Development (Dr. Shuki Mizutani, a Member of the Subcommittee)
- Reviewing Rare Cancers (Office of New Drug V, PMDA)
- Points to Consider and Future Plan
List of Handouts
- Document 1 The 3rd Subcommittee Minutes Summary
- Document 2 The 1st-3rd Subcommittee Discussion Summary
- Document 3 Lecture Materials (Dr. Taro Shibata, a Member)
- Document 4 Lecture Materials (Dr. Seiichi Matsumoto, a Member)
- Document 5 Lecture Materials (Dr. Shuki Mizutani, a Member)
- Document 6 Lecture Materials (Office of New Drug V, PMDA)